🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of ECP Therapy in Stable Angina Pectoris Patients

RecruitingNAAges 18 Years - anyAllUniversitas Padjadjaran
NCT04873687 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age \>= 18 years old * Diagnosed with stable angina pectoris * Anatomic vessel disease (VD) lesion with 2VD/3VD * Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery. * Not planned to urgent CABG * Minimum optimal medical therapy within 2 weeks * Able and willing to sign informed consent and comply with study procedures * The patient lives in Bandung City and its neighborhood * Retired patient; or not actively working during working hours; or willing to take the time to participate in research. Exclusion Criteria: * Congestive Heart Failure * Chronic heart failure with Functional Class NYHA III - IV * LVEF \<35% * Unprotected left main stenosis \>50% * Blood pressure \>180/110mmHg * Acute coronary syndrome * Acute Heart Failure * Severe aorta regurgitation * Malignant arrhythmia * Atrial fibrillation * Premature ventricular complex * Peripheral occlusive artery disease * Phlebitis * Deep vein thrombosis * Hemorrhagic diathesis * Severe chronic kidney disease * Aortic aneurysm * Abdominal aneurysm * Osteoarthritis * Low back pain * Pregnancy * Registered as other clinical study participant
💊

What it tests

  • External Counter Pulsation (ECP) therapy
📍

Where

1 site
Dr. Hasan Sadikin General Hospital
Bandung, Indonesia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy